Archived Newsletters
-
07.07.22 -- Ensuring A Consistent, High-Quality Biologic
7/7/2022
07/07/22 Outsourced Pharma Newsletter
-
07.06.22 -- Accelerating mAb Development To Meet mAb Market Demand
7/6/2022
07/06/22 Outsourced Pharma Newsletter
-
07.06.22 -- How Do You Due-Diligence Novartis?
7/6/2022
07/06/22 Outsourced Pharma Newsletter
-
07.01.22 -- Simplify And Accelerate The Development Pathway For APIs With Low Solubility
7/1/2022
07/01/22 Outsourced Pharma Newsletter
-
06.30.22 -- Efficient Pediatric Formulation Development Through Clinical Partnerships And Taste Masking
6/30/2022
06/30/22 Outsourced Pharma Newsletter
-
06.30.22 -- Regulatory Changes And Impact To Biosafety Testing: What You Should Know
6/30/2022
06/30/22 Outsourced Pharma Newsletter
-
06.29.22 -- Clinical Supply Optimization And Comparator Local Sourcing Strategies
6/29/2022
06/29/22 Outsourced Pharma Newsletter
-
06.29.22 -- Optimism Is Not A Strategy For Outsourcing
6/29/2022
06/29/22 Outsourced Pharma Newsletter
-
06.28.22 -- Insights On Outsourcing Highly Potent API Manufacturing
6/28/2022
06/28/22 Outsourced Pharma Newsletter
-
06.28.22 -- Advantages Of Nasal Administration Versus Oral Administration
6/28/2022
06/28/22 Outsourced Pharma Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more